Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Inverse association of Helicobacter pylori cagPAI genotypes with risk of cardia and non-cardia gastric adenocarcinoma.

Bakhti SZ, Latifi-Navid S, Zahri S, Yazdanbod A.

Cancer Med. 2019 Jul 5. doi: 10.1002/cam4.2390. [Epub ahead of print]

2.

Iranian Registry of Crohn's and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East.

Malekzadeh MM, Sima A, Alatab S, Sadeghi A, Daryani NE, Adibi P, Maleki I, Vossoughinia H, Fakheri H, Yazdanbod A, Taghavi SA, Aghazadeh R, Somi MH, Zendedel K, Vahedi H, Malekzadeh R.

Intest Res. 2019 Jul;17(3):330-339. doi: 10.5217/ir.2018.00157. Epub 2019 Apr 24.

3.

Are Helicobacter pylori highly cytotoxic genotypes and cardia gastric adenocarcinoma linked? Lessons from Iran.

Bakhti SZ, Latifi-Navid S, Zahri S, Bakhti FS, Hajavi N, Yazdanbod A.

Cancer Biomark. 2017 Dec 12;21(1):235-246. doi: 10.3233/CBM-170701.

PMID:
29036792
4.

Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran.

Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Safaralizadeh R.

Microb Pathog. 2017 Jun;107:287-292. doi: 10.1016/j.micpath.2017.04.007. Epub 2017 Apr 5.

PMID:
28390977
5.

Helicobacter pylori babA2 Positivity Predicts Risk of Gastric Cancer in Ardabil, a Very High-Risk Area in Iran.

Abdi E, Latifi-Navid S, Yazdanbod A, Zahri S.

Asian Pac J Cancer Prev. 2016;17(2):733-8.

6.

Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran.

Malekzadeh MM, Vahedi H, Gohari K, Mehdipour P, Sepanlou SG, Ebrahimi Daryani N, Zali MR, Mansour-Ghanaei F, Safaripour A, Aghazadeh R, Vossoughinia H, Fakheri H, Somi MH, Maleki I, Hoseini V, Ghadir MR, Daghaghzadeh H, Adibi P, Tavakoli H, Taghavi A, Zahedi MJ, Amiriani T, Tabib M, Alipour Z, Nobakht H, Yazdanbod A, Sadreddini M, Bakhshipour A, Khosravi A, Khosravi P, Nasseri-Moghaddam S, Merat S, Sotoudehmanesh R, Barazandeh F, Arab P, Baniasadi N, Pournaghi SJ, Parsaeian M, Farzadfar F, Malekzadeh R.

Arch Iran Med. 2016 Jan;19(1):2-15. doi: 0161901/AIM.003. Review.

7.

Relevance of Helicobacter pylori vacA 3'-end Region Polymorphism to Gastric Cancer.

Bakhti SZ, Latifi-Navid S, Mohammadi S, Zahri S, Bakhti FS, Feizi F, Yazdanbod A, Siavoshi F.

Helicobacter. 2016 Aug;21(4):305-16. doi: 10.1111/hel.12284. Epub 2015 Nov 27.

PMID:
26612250
8.

Effect of Helicobacter pylori eradication in Iranian patients with functional dyspepsia: a prospective, randomized, placebo-controlled trial.

Yazdanbod A, Salimian S, Habibzadeh S, Hooshyar A, Maleki N, Norouzvand M.

Arch Med Sci. 2015 Oct 12;11(5):964-9. doi: 10.5114/aoms.2015.54851.

9.

Relationship between Helicobacter pylori and idiopathic chronic urticaria: effectiveness of Helicobacter pylori eradication.

Mogaddam MR, Yazdanbod A, Ardabili NS, Maleki N, Isazadeh S.

Postepy Dermatol Alergol. 2015 Feb;32(1):15-20. doi: 10.5114/pdia.2015.48729. Epub 2015 Feb 2.

10.

Successful use of central venous catheters in the management of recurrent malignant pleural effusions: one new option.

Yazdanbod A, Salehifar A, Maleki N, Habibzadeh S, Tavosi Z.

Support Care Cancer. 2015 Aug;23(8):2267-71. doi: 10.1007/s00520-014-2595-3. Epub 2015 Jan 10.

PMID:
25576432
11.

Effects of p53 codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population.

Moradi MT, Salehi Z, Aminian K, Yazdanbod A.

Asian Pac J Cancer Prev. 2014;15(17):7413-7.

12.

Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis.

Sadjadi A, Yazdanbod A, Lee YY, Boreiri M, Samadi F, Alizadeh BZ, Islami F, Fyfe V, Babaei M, Namazi MJ, Going JJ, Sotoudeh M, de Bock GH, Malekzadeh R, Derakhshan MH.

PLoS One. 2013 Sep 30;8(9):e74440. doi: 10.1371/journal.pone.0074440. eCollection 2013.

13.

Decrease in gastric cancer susceptibility by MTHFR C677T polymorphism in Ardabil Province, Iran.

Hosseini-Asl SS, Pourfarzi F, Barzegar A, Mazani M, Farahmand N, Niasti E, Yazdanbod A, Didevar R, Akhavan H, Malekzadeh R.

Turk J Gastroenterol. 2013;24(2):117-21.

14.

Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions.

Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Parsaeian M, Babaei M, Alimohammadian M, Samadi F, Etemadi A, Pourfarzi F, Ahmadi E, Delavari A, Islami F, Farzadfar F, Sotoudeh M, Nikmanesh A, Alizadeh BZ, de Bock GH, Malekzadeh R.

Int J Cancer. 2014 Jan 1;134(1):181-8. doi: 10.1002/ijc.28344. Epub 2013 Aug 5.

15.

Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population.

Boreiri M, Samadi F, Etemadi A, Babaei M, Ahmadi E, Sharifi AH, Nikmanesh A, Houshiar A, Pourfarzai F, Yazdanbod A, Alimohammadian M, Sotoudeh M.

Arch Iran Med. 2013 Jun;16(6):343-7. doi: 013166/AIM.007.

16.

Helicobacter pylori vacA d1/-i1 genotypes and geographic differentiation between high and low incidence areas of gastric cancer in Iran.

Latifi-Navid S, Mohammadi S, Maleki P, Zahri S, Yazdanbod A, Siavoshi F, Massarrat S.

Arch Iran Med. 2013 Jun;16(6):330-7. doi: 013166/AIM.005.

17.
18.

Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?

Mohamadkhani A, Darvish Moghaddam S, Salmanroghani H, Allafsghari A, Yazdanbod A, Mirzaei M, Haj-sheykholeslami A, Bashiri J, Sadjadi A, Massarrat S.

Arch Iran Med. 2013 Apr;16(4):208-12. doi: 013164/AIM.003.

19.

Epidemiology of peptic ulcer disease: endoscopic results of a systematic investigation in iran.

Barazandeh F, Yazdanbod A, Pourfarzi F, Sepanlou SG, Derakhshan MH, Malekzadeh R.

Middle East J Dig Dis. 2012 Apr;4(2):90-6.

20.

Epidemiologic profile and clinical characteristics of ulcerative colitis in northwest of Iran: a 10-year review.

Yazdanbod A, Farzaneh E, Pourfarzi F, Azami A, Mostafazadeh B, Adiban V, Rasouli MR.

Trop Gastroenterol. 2010 Oct-Dec;31(4):308-11.

PMID:
21568148
21.

Dietary habits and gastric cancer risk in north-west Iran.

Pakseresht M, Forman D, Malekzadeh R, Yazdanbod A, West RM, Greenwood DC, Crabtree JE, Cade JE.

Cancer Causes Control. 2011 May;22(5):725-36. doi: 10.1007/s10552-011-9744-5. Epub 2011 Feb 24.

PMID:
21347819
22.

Mutations in Fanconi anemia genes and the risk of esophageal cancer.

Akbari MR, Malekzadeh R, Lepage P, Roquis D, Sadjadi AR, Aghcheli K, Yazdanbod A, Shakeri R, Bashiri J, Sotoudeh M, Pourshams A, Ghadirian P, Narod SA.

Hum Genet. 2011 May;129(5):573-82. doi: 10.1007/s00439-011-0951-7. Epub 2011 Jan 30.

PMID:
21279724
23.

Gastric cancer in Ardabil, Iran--a review and update on cancer registry data.

Babaei M, Pourfarzi F, Yazdanbod A, Chiniforush MM, Derakhshan MH, Mousavi SM, Samadi F, Rahimi G.

Asian Pac J Cancer Prev. 2010;11(3):595-9. Review.

24.

Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases.

Taghavi N, Nasrollahzadeh D, Merat S, Yazdanbod A, Hormazdi M, Sotoudeh M, Semnani S, Eslami F, Marjani HA, Fahimi S, Khademi H, Malekzadeh R.

World J Gastroenterol. 2007 Oct 28;13(40):5367-70.

25.

Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran.

Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, Malekzadeh R.

Arch Iran Med. 2007 Jan;10(1):32-7.

26.

Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran.

Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, Majidpour A, Babaei M, Mosavi A, Mohagheghi MA, Alimohammadian M.

Int J Cancer. 2003 Oct 20;107(1):113-8. Erratum in: Int J Cancer. Note: 2003 Dec 20;107(6):1059. Mohagheghi Mosavi, Mohammad Ali [corrected to Mohagheghi, Mohammad Ali].

27.

Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population.

Malekzadeh R, Merat S, Derakhshan MH, Siavoshi F, Yazdanbod A, Mikaeli J, Sotoudemanesh R, Sotoudeh M, Farahvash MJ, Nasseri-Moghaddam S, Pourshams A, Dolatshahi S, Abedi B, Babaei M, Arshi S, Majidpour A.

J Gastroenterol Hepatol. 2003 Jan;18(1):13-7.

PMID:
12519218

Supplemental Content

Loading ...
Support Center